These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37930356)

  • 1. Glucagon-like peptide-1 receptor activation stimulates PKA-mediated phosphorylation of Raptor and this contributes to the weight loss effect of liraglutide.
    Le TDV; Liu D; Besing GK; Raghavan R; Ellis BJ; Ceddia RP; Collins S; Ayala JE
    Elife; 2023 Nov; 12():. PubMed ID: 37930356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effects of metformin with liraglutide against endothelial dysfunction through GLP-1 receptor and PKA signalling pathway.
    Ke J; Liu Y; Yang J; Lu R; Tian Q; Hou W; Wang G; Wei R; Hong T
    Sci Rep; 2017 Feb; 7():41085. PubMed ID: 28145471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPCR signaling inhibits mTORC1 via PKA phosphorylation of Raptor.
    Jewell JL; Fu V; Hong AW; Yu FX; Meng D; Melick CH; Wang H; Lam WM; Yuan HX; Taylor SS; Guan KL
    Elife; 2019 May; 8():. PubMed ID: 31112131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liraglutide, a glucagon-like peptide-1 receptor agonist, facilitates osteogenic proliferation and differentiation in MC3T3-E1 cells through phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT), extracellular signal-related kinase (ERK)1/2, and cAMP/protein kinase A (PKA) signaling pathways involving β-catenin.
    Wu X; Li S; Xue P; Li Y
    Exp Cell Res; 2017 Nov; 360(2):281-291. PubMed ID: 28919123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor-21 is required for weight loss induced by the glucagon-like peptide-1 receptor agonist liraglutide in male mice fed high carbohydrate diets.
    Le TDV; Fathi P; Watters AB; Ellis BJ; Besing GK; Bozadjieva-Kramer N; Perez MB; Sullivan AI; Rose JP; Baggio LL; Koehler J; Brown JL; Bales MB; Nwaba KG; Campbell JE; Drucker DJ; Potthoff MJ; Seeley RJ; Ayala JE
    Mol Metab; 2023 Jun; 72():101718. PubMed ID: 37030441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-like Peptide-1 receptor Tie2+ cells are essential for the cardioprotective actions of liraglutide in mice with experimental myocardial infarction.
    McLean BA; Wong CK; Kabir MG; Drucker DJ
    Mol Metab; 2022 Dec; 66():101641. PubMed ID: 36396031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oleoylethanolamide modulates glucagon-like peptide-1 receptor agonist signaling and enhances exendin-4-mediated weight loss in obese mice.
    Brown JD; McAnally D; Ayala JE; Burmeister MA; Morfa C; Smith L; Ayala JE
    Am J Physiol Regul Integr Comp Physiol; 2018 Oct; 315(4):R595-R608. PubMed ID: 29949410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liraglutide ameliorates palmitate-induced oxidative injury in islet microvascular endothelial cells through GLP-1 receptor/PKA and GTPCH1/eNOS signaling pathways.
    Le Y; Wei R; Yang K; Lang S; Gu L; Liu J; Hong T; Yang J
    Peptides; 2020 Feb; 124():170212. PubMed ID: 31770577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GDF15 acts synergistically with liraglutide but is not necessary for the weight loss induced by bariatric surgery in mice.
    Frikke-Schmidt H; Hultman K; Galaske JW; Jørgensen SB; Myers MG; Seeley RJ
    Mol Metab; 2019 Mar; 21():13-21. PubMed ID: 30685336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robust anti-obesity and metabolic effects of a dual GLP-1/glucagon receptor peptide agonist in rodents and non-human primates.
    Henderson SJ; Konkar A; Hornigold DC; Trevaskis JL; Jackson R; Fritsch Fredin M; Jansson-Löfmark R; Naylor J; Rossi A; Bednarek MA; Bhagroo N; Salari H; Will S; Oldham S; Hansen G; Feigh M; Klein T; Grimsby J; Maguire S; Jermutus L; Rondinone CM; Coghlan MP
    Diabetes Obes Metab; 2016 Dec; 18(12):1176-1190. PubMed ID: 27377054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of mTOR complex 1 (mTORC1) by raptor Ser863 and multisite phosphorylation.
    Foster KG; Acosta-Jaquez HA; Romeo Y; Ekim B; Soliman GA; Carriere A; Roux PP; Ballif BA; Fingar DC
    J Biol Chem; 2010 Jan; 285(1):80-94. PubMed ID: 19864431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism.
    Mroz PA; Finan B; Gelfanov V; Yang B; Tschöp MH; DiMarchi RD; Perez-Tilve D
    Mol Metab; 2019 Feb; 20():51-62. PubMed ID: 30578168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic Fibroblast Growth Factor 21 Is Involved in Mediating Functions of Liraglutide in Mice With Dietary Challenge.
    Liu D; Pang J; Shao W; Gu J; Zeng Y; He HH; Ling W; Qian X; Jin T
    Hepatology; 2021 Oct; 74(4):2154-2169. PubMed ID: 33851458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of brown adipose tissue activity to the control of energy balance by GLP-1 receptor signalling in mice.
    Heppner KM; Marks S; Holland J; Ottaway N; Smiley D; Dimarchi R; Perez-Tilve D
    Diabetologia; 2015 Sep; 58(9):2124-32. PubMed ID: 26049402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Neuroprotective Effect of Liraglutide is Mediated by Glucagon-Like Peptide 1 Receptor-Mediated Activation of cAMP/PKA/CREB Pathway.
    Bao Y; Jiang L; Chen H; Zou J; Liu Z; Shi Y
    Cell Physiol Biochem; 2015; 36(6):2366-78. PubMed ID: 26279440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial GLP-1 (Glucagon-Like Peptide-1) Receptor Mediates Cardiovascular Protection by Liraglutide In Mice With Experimental Arterial Hypertension.
    Helmstädter J; Frenis K; Filippou K; Grill A; Dib M; Kalinovic S; Pawelke F; Kus K; Kröller-Schön S; Oelze M; Chlopicki S; Schuppan D; Wenzel P; Ruf W; Drucker DJ; Münzel T; Daiber A; Steven S
    Arterioscler Thromb Vasc Biol; 2020 Jan; 40(1):145-158. PubMed ID: 31747801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liraglutide Improves Endothelial Function via the mTOR Signaling Pathway.
    Wu H; Xiao C; Zhao Y; Yin H; Yu M
    J Diabetes Res; 2021; 2021():2936667. PubMed ID: 34447854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The autonomic nervous system and cardiac GLP-1 receptors control heart rate in mice.
    Baggio LL; Ussher JR; McLean BA; Cao X; Kabir MG; Mulvihill EE; Mighiu AS; Zhang H; Ludwig A; Seeley RJ; Heximer SP; Drucker DJ
    Mol Metab; 2017 Nov; 6(11):1339-1349. PubMed ID: 29107282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase A-mediated phosphorylation of the beta 2-adrenergic receptor regulates its coupling to Gs and Gi. Demonstration in a reconstituted system.
    Zamah AM; Delahunty M; Luttrell LM; Lefkowitz RJ
    J Biol Chem; 2002 Aug; 277(34):31249-56. PubMed ID: 12063255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual melanocortin-4 receptor and GLP-1 receptor agonism amplifies metabolic benefits in diet-induced obese mice.
    Clemmensen C; Finan B; Fischer K; Tom RZ; Legutko B; Sehrer L; Heine D; Grassl N; Meyer CW; Henderson B; Hofmann SM; Tschöp MH; Van der Ploeg LH; Müller TD
    EMBO Mol Med; 2015 Mar; 7(3):288-98. PubMed ID: 25652173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.